Quanterix Corporation announced the appointment of Everett Cunningham as the next President and Chief Executive Officer.
The leadership transition is set to take place on January 19, 2026.
Everett Cunningham, currently Chief Commercial Officer of Illumina, brings valuable experience in healthcare and commercial strategy.
Leadership Transition
Everett Cunningham appointed as President and CEO, succeeding Masoud Toloue on January 19, 2026.
Revenue Expectations
Company anticipates exceeding revenue and cash guidance for full year 2025.
Experience and Background
Cunningham's extensive experience includes roles at Illumina, Exact Sciences, Quest Diagnostics, GE Healthcare, and Pfizer.
- The appointment of Everett Cunningham signals Quanterix's focus on growth and innovation in healthcare.
- Cunningham's track record in building commercial organizations and driving operational excellence aligns with Quanterix's goals for advancement.
Quanterix is positioned for further growth and value creation under the leadership of Everett Cunningham, leveraging his expertise in commercial strategy and healthcare industry.